In 2107, *Cellular and Molecular Gastroenterology and Hepatology* is pleased to honor the 25th anniversary of the AGA--R. Robert and Sally Funderburg Research Award in Gastric Cancer with a compendium of reviews and commentaries written by recipients of this award. The AGA--R. Robert and Sally Funderburg Research Award in Gastric Cancer recognizes and supports an established investigator whose research will enhance the fundamental understanding of gastric cancer pathobiology to ultimately prevent, or develop a cure for, the disease.

Although gastric cancer prevalence has decreased in the United States, the mortality rate remains dismal. Worldwide, gastric cancer has remained one of the top 3 causes of cancer-related death. The generosity of the Funderburg Family in creating this award has occupied a unique position in the support of gastrointestinal research by providing funding for a field of research that traditionally has been underfunded in the United States. The Funderburg Award has enabled American investigators to pursue studies into and advance our understanding of gastric cancer.

The articles in this issue of *Cellular and Molecular Gastroenterology and Hepatology* deal with a wide range of subjects relevant to gastric cancer biology. These include consideration of preneoplastic metaplasia, critical signaling pathways in promoting metaplasia and neoplasia, and the role of genetics in characterization and classification of gastric cancers. These articles discuss many of the breakthroughs that have been made possible by the Funderburg Award and the great progress in understanding gastric carcinogenesis that has been made over the past 25 years. These articles also delineate challenges for the future, including understanding the origin of preneoplastic lesions, the mechanisms responsible for cancer stem cell evolution, and the challenges for directed gastric cancer treatment.

We hope that these articles will inspire more investigators, perhaps future Funderburg Awardees, to address and solve the remaining questions that will realize the goals of improved gastric cancer diagnosis and treatment.
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